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A commentary on
Acute Myocardial Response to Stretch: What We (don’t) Know
by Neves, J. S., Leite-Moreira, A. M., Neiva-Sousa, M., Almeida-Coelho, J., Castro-Ferreira, R., and
Leite-Moreira, A. F. (2016). Front. Physiol. 6:408. doi: 10.3389/fphys.2015.00408
Recently, Neves and colleagues reviewed some of the factors that orchestrate acute myocardial
response to stretch (Neves et al., 2015). We would like to compliment the authors for their
interesting work. They addressed the most extensively studied pathways for hemodynamic
stress alleviation. According to their comments, well-characterized mechanisms, Frank-Starling
Mechanism (FSM) and Slow Force Response (SFR) are contributed in the systolic adaptation
of heart (Kockskämper et al., 2008; Neves et al., 2015). However, they have not paid attention
to the role of apelinergic system as a relatively new player which can be involved in the SFR
mechanism. Decreased heart contractility in apelin gene-deficient mice associated with pressure
overload and aging and also significant lower of the cardiomyocyte Frank-Starling gain in apelin
receptor-knockout mice are evidences in favor of involvement of apelinergic system in cardiac
contractility aspects (Kuba et al., 2007). This system can couple to the angiotensin receptor
like-1 (APJ), an orphan G protein-coupled receptor, and it is able to function as a bimodal
switch. Based on the applied stimulus, it can translate different chemical (apelin) and mechanical
(stretch) signals into opposite phenotypical behavior by modulating the levels of activation of
G-protein signaling vs β-arrestin signaling (Scimia et al., 2012; Gerilechaogetu et al., 2014).
When mechanical stretch is superimposed on apelin stimulation, the APJ activation interferes
with apelin mediated G-protein signaling (G-protein-independent-β-arrestin-dependent signaling
pathway). This leads to a pathologic stretch-mediated hypertrophy (apelin-independent effects
of APJ) that could be minimizing by administering of apelin or knocking-down beta-arrestins
(Scimia et al., 2014). On the other hand, activation of APJ by apelin can regulate cardiac
contractility through various signaling mechanisms (Figure 1). Apelin induces a slowly developing
but sustained myocardial contraction (Slow Force Response) at sub-nanomolar concentrations and
engages in the maintaining of intercellular communication and electrophysiological properties
of cardiac tissue (Szokodi et al., 2002; Farkasfalvi et al., 2007; Scimia et al., 2014). In line with
these reports, acute apelin infusion increases the cardiac output and load-independent measures of
myocardial contractility (such as ventricular elastance and preload recruitable stroke work) whereas
chronic administration exerts an increase in the cardiac output without inducing left ventricular
hypertrophy (Japp and Newby, 2008; Scimia et al., 2014).
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FIGURE 1 | Apelinergic signaling pathway. G protein-dependent, including PTX-sensitive and -insensitive pathways; and G protein-independent pathway,
mediating the effects of apelin receptor (Kalea and Batlle, 2010; Chen et al., 2014). In contrary to dominant stretch that causes β-arrestin-mediated pathologic
hypertrophy, apelin through APJ and G proteins can induce inotropic effects and plays a protective role. There is a functional interplay between apelin and stretch,
such that apelin blunts pathological signaling from the stretch and stretch in turn profoundly interferes (via β-arrestins) with G-protein activation relevant to apelin
signaling. Progressive increase in Ca2+ transient is the central player in the positive inotropic effect of apelin (Wang et al., 2008; Neves et al., 2015). As it shown, apelin
through increasing of RyR2 channel (Wang et al., 2008), NCX (Szokodi et al., 2002; Japp and Newby, 2008), PLB and SERCA activity (Wang et al., 2008), provide the
Ca2+ required for contraction. The Ca2+ molecules subsequently bind to the contractile proteins such as TnC, which causes interaction of thick and thin filaments
(Sussman et al., 2011; Gerilechaogetu et al., 2014). Besides RLC activation by PKC (sustained, fine-tuning regulation of contraction), PKC-mediated phosphorylation
of NHE and NCX is essential for the maintenance of the increased contractility and for the prevention of the slow force decline (Perjés et al., 2014; Neves et al., 2015).
It is noteworthy that the intracellular signals via PKC-ERK axis and Akt phosphorylation can be downstream elements of PTX-sensitive fashion of apelinergic system.
Improving of calcium handling (direct or indirect modification of calcium cycling proteins), increasing of Ca2+ loading of SR along with translocation of AKT to the SR
(due to increased of PLB phosphorylation), and increasing of the SERCA-PLB activity (via downregulation of phosphatase PP1) are proposed mechanisms for the
increased contractility by cardiac specific AKT (Sussman et al., 2011; Gerilechaogetu et al., 2014). Interestingly, Wang et al. demonstrated that SR Ca2+ content is
decreased by apelin and greater increase of NCX activity than that of SERCA activity, is proposed as an explanation (Wang et al., 2008). APJ, Angiotensin receptor
like-1; PLC, phospholipase C; IP3, inositol trisphosphate; SR, sarcoplasmic reticulum; SERCA, sarco/endoplasmic reticulum Ca2+ ATPase; PLB, phospholamban;
RyR2, ryanodine receptor; DAG, diacylglycerol; PKC, protein kinase C; MLCK, myosin light chain kinase; TnI, troponin I; RLC, myosin regulatory light chain; MAPK,
Mitogen-activated protein kinase; ERK1/2, extracellular signal-regulated kinase 1/2; NHE, Na+/H+ exchanger; NCX, Na+/Ca2+ exchanger; AC, adenyl cyclase; ATP,
adenosine triphosphate; cAMP, cyclic adenosine monophosphate; PKA, protein kinase A; PI3K, phosphoinositide 3-kinase; AKT, protein kinase B; Gi, inhibitory G
protein; Gq, phospholipase C-activating G protein; SFR, slow force response; TnC, troponin C;→, Stimulatory effect; ⊣, Inhibitory effect.
Apelin can enhance cardiac contractility via both pertussis
toxin (PTX)-sensitive and -insensitive G proteins (Gαi and Gαq,
respectively) but independent of angiotensin II, endothelin-
1, catecholamines, and nitric oxide (Perjés et al., 2014;
Scimia et al., 2014). Increasing in phospholipase C activity
(especially PLCβ) besides activating inositol trisphosphate
(protein kinase C-independent pathway) (Yang et al., 2015)
can trigger downstream signaling cascades by induction of
phosphoinositide hydrolysis and diacylglycerol-mediated PKC
activation (PKC-dependent pathway) (Szokodi et al., 2002; Japp
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and Newby, 2008). There are accumulating lines of evidence
which suggest that the protein kinase C (PKC) activation a
crucial messenger for the evoked positive inotropic response
of apelin. PKC can phosphorylate the sarcolemmal Na+/H+
exchanger (NHE), myosin light chain kinase (MLCK) and
mitogen-activated protein kinase (MAPK), resulting in a strong
positive inotropic effect (Szokodi et al., 2002; Perjés et al.,
2014) (Figure 1). Cytoplasmic alkalinization that drives up-
regulation of hypertrophic genes and increasing protein synthesis
along with subsequent sensitization of cardiac myofilaments to
intracellular Ca2+ (without altering cytoplasmic Ca2+ transients
and voltage-gated Ca2+ channels) are direct effects of NHE
activation (Szokodi et al., 2002; Farkasfalvi et al., 2007; Japp and
Newby, 2008). On the other hand, NHE-mediated accumulation
of intracellular Na+ can indirectly promote a rise in Ca2+
concentration within cells via reverse mode Na+/Ca2+ exchanger
(NCX) (Szokodi et al., 2002; Japp and Newby, 2008). Therefore, it
is plausible to assume that NHE and NCX are proximal and distal
components of a contiguous signaling pathway respectively,
and apelin can stimulate myocardial contractility by enhancing
myofilament responsiveness to Ca2+ (transitory form) along
with increase intracellular Ca2+ availability (SFR) (Farkasfalvi
et al., 2007; Japp and Newby, 2008; Gerilechaogetu et al.,
2014; Perjés et al., 2014). In addition, apelin may increase
the Ca2+-sensitivity of the contractile machinery through
cardiac MLCK activation. This Ca2+/calmodulin-independent
isoform has potential phosphorylation sites for PKC. Therefore,
collaboration of PKC-dependent myosin regulatory light chain
(RLC) and troponin I (TnI) phosphorylation can more improve
the cardiac contractility (Perjés et al., 2014; Neves et al., 2015).
Recent studies suggest that PKC and ERK1/2 are parallel and
independent signaling pathways mediating the inotropic effect of
apelin (Malo et al., 2007; Gerilechaogetu et al., 2014). Moreover,
apelin via APJ activation can increase angiotensin converting
enzyme 2 (ACE2) promoter activity and ACE2 expression, which
improved the cardiac functions independently of AT1R signaling
(Sato et al., 2013).
Colocalization of PKCε and Focal Adhesion Kinase
(FAK) to costameres and focal adhesions and the relation
of FAK activity to various signaling pathways such as G
protein-coupled receptors (ERK1/2 and PKCε), raises the
possibility that there is a link between apelinergic system and
integrin-mediated signaling (Heidkamp et al., 2003). However,
additional evaluations will be required to substantiate this
possibility.
In conclusion, given a wide array of putative salutary effects
of apelinergic system on heart contractile reserve, it can be
considered as the other contributor which engages in the cardiac
contractility response, especially in the SFR mechanism, to acute
hemodynamic overload.
AUTHOR CONTRIBUTIONS
SJ developed the idea and contributed to preparation of
paper. RV contributed to preparation of paper and figure
design.
REFERENCES
Chen, X., Bai, B., Tian, Y., Du, H., and Chen, J. (2014). Identification
of serine 348 on the apelin receptor as a novel regulatory
phosphorylation site in apelin-13-induced G protein-independent biased
signaling. J. Biol. Chem. 289, 31173–31187. doi: 10.1074/jbc.M114.
574020
Farkasfalvi, K., Stagg, M. A., Coppen, S. R., Siedlecka, U., Lee, J., Soppa, G.
K., et al. (2007). Direct effects of apelin on cardiomyocyte contractility
and electrophysiology. Biochem. Biophys. Res. Commun. 357, 889–895.
doi: 10.1016/j.bbrc.2007.04.017
Gerilechaogetu, F., Feng, H., Golden, H. B., Nizamutdinov, D., Dostal, J. D.,
Jacob, J. C., et al. (2014). Current concepts in the role of mechanosensing
in the regulation of cardiac contractile function. Austin. J. Clin. Med.
1:11015.
Heidkamp, M. C., Bayer, A. L., Scully, B. T., Eble, D. M., and Samarel, A. M.
(2003). Activation of focal adhesion kinase by protein kinase Cǫ in neonatal rat
ventricular myocytes. Am. J. Physiol. Heart Circ. Physiol. 285, H1684–H1696.
doi: 10.1152/ajpheart.00016.2003
Japp, A. G., and Newby, D. E. (2008). The apelin-APJ system in heart failure:
pathophysiologic relevance and therapeutic potential. Biochem. Pharmacol. 75,
1882–1892. doi: 10.1016/j.bcp.2007.12.015
Kalea, A. Z., and Batlle, D. (2010). Apelin and ACE2 in cardiovascular disease.
Curr. Opin. Investig. Drugs. 11, 273–282.
Kockskämper, J., von Lewinski, D., Khafaga, M., Elgner, A., Grimm, M.,
Eschenhagen, T., et al. (2008). The slow force response to stretch in atrial
and ventricular myocardium from human heart: functional relevance and
subcellular mechanisms. Prog. Biophys. Mol. Biol. 97, 250–267. doi: 10.1016/j.
pbiomolbio.2008.02.026
Kuba, K., Zhang, L., Imai, Y., Arab, S., Chen, M., Maekawa, Y., et al.
(2007). Impaired heart contractility in Apelin gene-deficient mice
associated with aging and pressure overload. Circ. Res. 101, e32–e42.
doi: 10.1161/circresaha.107.158659
Malo, M. E., Li, L., and Fliegel, L. (2007). Mitogen-activated
protein kinase-dependent activation of the Na+/H+ exchanger
is mediated through phosphorylation of amino acids Ser770 and
Ser771. J. Biol. Chem. 282, 6292–6299. doi: 10.1074/jbc.M6110
73200
Neves, J. S., Leite-Moreira, A. M., Neiva-Sousa, M., Almeida-Coelho, J.,
Castro-Ferreira, R., and Leite-Moreira, A. F. (2015). Acute myocardial
response to stretch: what we (don’t) know. Front. Physiol. 6:408.
doi: 10.3389/fphys.2015.00408
Perjés, Á., Skoumal, R., Tenhunen, O., Kónyi, A., Simon, M.,
Horváth, I. G., et al. (2014). Apelin increases cardiac contractility
via protein kinase Cε-and extracellular signal-regulated kinase-
dependent mechanisms. PLoS ONE 9:e93473. doi: 10.1371/journal.pone.
0093473
Sato, T., Suzuki, T., Watanabe, H., Kadowaki, A., Fukamizu, A., Liu, P. P., et al.
(2013). Apelin is a positive regulator of ACE2 in failing hearts. J. Clin. Invest.
123, 5203–5211. doi: 10.1172/JCI69608
Scimia, M. C., Blass, B. E., and Koch, W. J. (2014). Apelin receptor:
its responsiveness to stretch mechanisms and its potential for
cardiovascular therapy. Expert Rev. Cardiovasc. Ther. 12, 733–741.
doi: 10.1586/14779072.2014.911661
Scimia, M. C., Hurtado, C., Ray, S., Metzler, S., Wei, K., Wang, J., et al. (2012).
APJ acts as a dual receptor in cardiac hypertrophy. Nature 488, 394–398.
doi: 10.1038/nature11263
Sussman, M. A., Völkers, M., Fischer, K., Bailey, B., Cottage, C. T., Din, S., et al.
(2011). Myocardial AKT: the omnipresent nexus. Physiol. Rev. 91, 1023–1070.
doi: 10.1152/physrev.00024.2010
Szokodi, I., Tavi, P., Földes, G., Voutilainen-Myllylä, S., Ilves, M., Tokola,
H., et al. (2002). Apelin, the novel endogenous ligand of the orphan
Frontiers in Physiology | www.frontiersin.org 3 March 2017 | Volume 8 | Article 121
Vahidi and Joukar Apelinergic System and Heart Contractility
receptor APJ, regulates cardiac contractility. Circ. Res. 91, 434–440.
doi: 10.1161/01.RES.0000033522.37861.69
Wang, C., Du, J. F., Wu, F., and Wang, H. C. (2008). Apelin decreases the SR
Ca2+ content but enhances the amplitude of [Ca2+]i transient and contractions
during twitches in isolated rat cardiac myocytes. Am. J. Physiol. Heart Circ.
Physiol. 294, H2540–H2546. doi: 10.1152/ajpheart.00046.2008
Yang, P., Maguire, J. J., and Davenport, A. P. (2015). Apelin, Elabela/Toddler,
and biased agonists as novel therapeutic agents in the cardiovascular
system. Trends Pharmacol. Sci. 36, 560–567. doi: 10.1016/j.tips.2015.
06.002
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2017 Vahidi and Joukar. This is an open-access article distributed
under the terms of the Creative Commons Attribution License (CC BY). The use,
distribution or reproduction in other forums is permitted, provided the original
author(s) or licensor are credited and that the original publication in this journal
is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Frontiers in Physiology | www.frontiersin.org 4 March 2017 | Volume 8 | Article 121
